First-line erlotinib and bevacizumab in patients with locally advanced and/or metastatic non-small-cell lung cancer: a phase II study including molecular imaging

A.M.C. Dingemans; A.J. de Langen; V. van den Boogaart; J.T. Marcus; W.H. Backes; H.T.G.M. Scholtens; H. van Tinteren; O.S. Hoekstra; J. Pruim; B. Brans; F.B. Thunnissen; E.F. Smit; H.J.M. Groen

doi:https://doi.org/10.1093/annonc/mdq391

First-line erlotinib and bevacizumab in patients with locally advanced and/or metastatic non-small-cell lung cancer: a phase II study including molecular imaging

A.M.C. Dingemans, A.J. de Langen, V. van den Boogaart, J.T. Marcus, W.H. Backes, H.T.G.M. Scholtens, H. van Tinteren, O.S. Hoekstra, J. Pruim, B. Brans, F.B. Thunnissen, E.F. Smit, H.J.M. Groen

Research output: Contribution to journal › Article › Academic › peer-review

64 Citations (Scopus)

Original language	English
Pages (from-to)	559-566
Journal	Annals of Oncology
Volume	22
Issue number	3
DOIs	https://doi.org/10.1093/annonc/mdq391
Publication status	Published - 2011

Access to Document

https://doi.org/10.1093/annonc/mdq391

Cite this

Dingemans, A. M. C., de Langen, A. J., van den Boogaart, V., Marcus, J. T., Backes, W. H., Scholtens, H. T. G. M., van Tinteren, H., Hoekstra, O. S., Pruim, J., Brans, B., Thunnissen, F. B., Smit, E. F., & Groen, H. J. M. (2011). First-line erlotinib and bevacizumab in patients with locally advanced and/or metastatic non-small-cell lung cancer: a phase II study including molecular imaging. Annals of Oncology, 22(3), 559-566. https://doi.org/10.1093/annonc/mdq391

@article{62c48a83f99e41c5b62715a35b3b8ea3,

title = "First-line erlotinib and bevacizumab in patients with locally advanced and/or metastatic non-small-cell lung cancer: a phase II study including molecular imaging",

author = "A.M.C. Dingemans and {de Langen}, A.J. and {van den Boogaart}, V. and J.T. Marcus and W.H. Backes and H.T.G.M. Scholtens and {van Tinteren}, H. and O.S. Hoekstra and J. Pruim and B. Brans and F.B. Thunnissen and E.F. Smit and H.J.M. Groen",

year = "2011",

doi = "https://doi.org/10.1093/annonc/mdq391",

language = "English",

volume = "22",

pages = "559--566",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

number = "3",

}

Dingemans, AMC, de Langen, AJ, van den Boogaart, V, Marcus, JT, Backes, WH, Scholtens, HTGM, van Tinteren, H, Hoekstra, OS, Pruim, J, Brans, B, Thunnissen, FB, Smit, EF & Groen, HJM 2011, 'First-line erlotinib and bevacizumab in patients with locally advanced and/or metastatic non-small-cell lung cancer: a phase II study including molecular imaging', Annals of Oncology, vol. 22, no. 3, pp. 559-566. https://doi.org/10.1093/annonc/mdq391

TY - JOUR

T1 - First-line erlotinib and bevacizumab in patients with locally advanced and/or metastatic non-small-cell lung cancer: a phase II study including molecular imaging

AU - Dingemans, A.M.C.

AU - de Langen, A.J.

AU - van den Boogaart, V.

AU - Marcus, J.T.

AU - Backes, W.H.

AU - Scholtens, H.T.G.M.

AU - van Tinteren, H.

AU - Hoekstra, O.S.

AU - Pruim, J.

AU - Brans, B.

AU - Thunnissen, F.B.

AU - Smit, E.F.

AU - Groen, H.J.M.

PY - 2011

Y1 - 2011

U2 - https://doi.org/10.1093/annonc/mdq391

DO - https://doi.org/10.1093/annonc/mdq391

M3 - Article

C2 - 20702788

SN - 0923-7534

VL - 22

SP - 559

EP - 566

JO - Annals of Oncology

JF - Annals of Oncology

IS - 3

ER -